Dwarf milkwort
Polygala japonica
Polygala japonica, a traditional plant, is primarily associated with East Asian medicine practices. While its specific uses in these traditions are not well-documented, studies have shown promising results for its potential pharmacological activities. Scientific evidence indicates that Polygala japonica, particularly through the compound polygalasaponin F, may reduce neurological deficits and brain edema following stroke by targeting NKCC1 via epigenetic mechanisms. It also appears to improve nonalcoholic steatohepatitis in mice by modulating gut microbiota and affecting liver and fecal metabolites. However, these findings are largely based on animal studies and require further clinical validation. No major safety concerns or known drug interactions have been recorded for Polygala japonica, but its efficacy and broader applications remain to be fully explored through human trials.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Polygalasaponin F from Polygala japonica reduced neurological deficits and brain edema in stroke models by targeting NKCC1 through epigenetic mechanisms.
- Polygalasaponin F treatment reduced neurological and pathological scores in middle cerebral artery occlusion-induced focal ischemia rats by inhibiting the TXNIP/NLRP3 signaling pathway.
- Polygala japonica improved nonalcoholic steatohepatitis in mice by modulating gut microbiota and affecting liver and fecal metabolites.
- This review compiles evidence suggesting Polygala japonica has multiple potential pharmacological activities but requires further clinical validation.
Frequently asked questions
What is Dwarf milkwort?
Dwarf milkwort (Polygala japonica) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Dwarf milkwort?
4 sourced findings are recorded for Dwarf milkwort; the strongest carries evidence grade D. For example: Polygalasaponin F from Polygala japonica reduced neurological deficits and brain edema in stroke models by targeting NKCC1 through epigenetic mechanisms.
How strong is the evidence for Dwarf milkwort?
The strongest finding for Dwarf milkwort carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Dwarf milkwort safe? What are the side effects?
No major safety issues are recorded for Dwarf milkwort in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Dwarf milkwort interact with medications?
No drug interactions are recorded for Dwarf milkwort in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Dwarf milkwort?
Dwarf milkwort is also known as: Истод японский.
Is Dwarf milkwort a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Aqueous extract of Polygala japonica Houtt. ameliorated nonalcoholic steatohepatitis in mice through restoring the gut microbiota disorders and affecting the metabolites in feces and liver. literature abstract metadata
- T2 Polygalasaponin F ameliorates middle cerebral artery occlusion-induced focal ischemia / reperfusion injury in rats through inhibiting TXNIP/NLRP3 signaling pathway. literature abstract metadata
- T2 Polygala japonica Houtt.: A comprehensive review on its botany, traditional uses, phytochemistry, pharmacology, and pharmacokinetics. literature abstract metadata
- T2 Mechanisms of polygalasaponin F against brain ischemia-reperfusion injury by targeting NKCC1. literature abstract metadata